New Key Statistics Module, Z-Score and F-Score
NYSE:WST Key Ratios
Market Cap $ M | 21,964.14 |
Enterprise Value $ M | 21,828.64 |
P/E(ttm) | 43.07 |
PE Ratio without NRI | 42.83 |
Forward PE Ratio | 46.50 |
Price/Book | 8.53 |
Price/Sales | 7.84 |
Price/Free Cash Flow | 63.34 |
Price/Owner Earnings | 47.28 |
Payout Ratio % | 0.11 |
Revenue (TTM) $ M | 2,876.00 |
EPS (TTM) $ | 7.03 |
Beneish M-Score | -2.85 |
10-y EBITDA Growth Rate % | 15.00 |
5-y EBITDA Growth Rate % | 22.00 |
y-y EBITDA Growth Rate % | 4.30 |
EV-to-EBIT | 35.29 |
EV-to-EBITDA | 28.55 |
PEG | 1.95 |
Shares Outstanding M | 72.54 |
Net Margin (%) | 18.25 |
Operating Margin % | 21.14 |
Pre-tax Margin (%) | 21.25 |
Quick Ratio | 1.68 |
Current Ratio | 2.34 |
ROA % (ttm) | 14.31 |
ROE % (ttm) | 19.08 |
ROIC % (ttm) | 19.43 |
Dividend Yield % | 0.26 |
Altman Z-Score | 17.63 |
WST Number of Guru Trades
WST Volume of Guru Trades
Gurus Latest Trades with NYSE:WST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:WST is held by these investors
Total 4
West Pharmaceutical Services Inc Insider Transactions
No Available Data
News about NYSE:WST
Total 0- 1